Cardiovascular management of cancer patients with chemotherapy-associated left ventricular systolic dysfunction in real-world clinical practice

Journal of Cardiac Failure

Volumn 19, Issue 9, 2013, Pages 629-634

  Ammon, Michael ^a   Arenja, Nisha ^a   Leibundgut, Gregor ^a   Buechel, Ronny R ^a   Kuster, Gabriela M ^a   Kaufmann, Beat A ^a   Pfister, Otmar ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

cardiomyopathy; chemotherapy; Heart failure; medical treatment

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSULFAN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; FLUOROURACIL; IDARUBICIN; IFOSFAMIDE; MELPHALAN; MITOXANTRONE; NAVELBINE; PACLITAXEL; RITUXIMAB; TRASTUZUMAB; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER THERAPY; CLINICAL PRACTICE; CONSULTATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT CARE; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL RATE;

CARDIOMYOPATHY; CHEMOTHERAPY; HEART FAILURE; MEDICAL TREATMENT;

AGED; ANTINEOPLASTIC AGENTS; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84884535755     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2013.07.007     Document Type: Article

References (19)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. American Cancer Society. Cancer facts and figures 2012. Available at: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/ document/acspc-031941.pdf
3. E.T. Yeh, and C.L. Bickford Cardiovascular complications of cancer therapy: Incidence, pathogenesis, diagnosis, and management J Am Coll Cardiol 53 2009 2231 2247
4. S.M. Swain, F.S. Whaley, and M.S. Ewer Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials Cancer 97 2003 2869 2879 (Pubitemid 36605157)
5. M.A. Goldberg, J.H. Antin, E.C. Guinan, and J.M. Rappeport Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor Blood 68 1986 1114 1118 (Pubitemid 17186389)
6. T.J. Wang, J.C. Evans, E.J. Benjamin, D. Levy, E.C. LeRoy, and R.S. Vasan Natural history of asymptomatic left ventricular systolic dysfunction in the community Circulation 108 2003 977 982 (Pubitemid 37048228)
7. P.S. Douglas, B. Khandheria, R.F. Stainback, N.J. Weissman, R.G. Brindis, M.R. Patel American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American College of Chest Physicians, Society of Critical Care Medicine ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography J Am Coll Cardiol 50 2007 187 204
8. S.A. Hunt, W.T. Abraham, M.H. Chin, A.M. Feldman, G.S. Francis, and T.G. Ganiats 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 2009 e391 e479
9. D. Cardinale, A. Colombo, G. Lamantia, N. Colombo, M. Civelli, and G. de Giacomi Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy J Am Coll Cardiol 55 2010 213 220
10. M.A. Grenier, and S.E. Lipshultz Epidemiology of anthracycline cardiotoxicity in children and adults Semin Oncol 25 1998 72 85 (Pubitemid 28460388)
11. S.E. Lipshultz, J.A. Alvarez, and R.E. Scully Anthracycline associated cardiotoxicity in survivors of childhood cancer Heart 94 2008 525 533 (Pubitemid 351441417)
12. G.J. Yoon, M.L. Telli, D.P. Kao, K.Y. Matsuda, R.W. Carlson, and R.M. Witteles Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally? J Am Coll Cardiol 56 2010 1644 1650
13. J.A. Ezekowitz, C. van Walraven, F.A. McAlister, P.W. Armstrong, and P. Kaul Impact of specialist follow-up in outpatients with congestive heart failure CMAJ 172 2005 189 194
14. A. Rao, and J. Walsh Impact of specialist care in patients with newly diagnosed heart failure: a randomised controlled study Int J Cardiol 115 2007 196 202 (Pubitemid 46136521)
15. P. Jong, Y. Gong, P.P. Liu, P.C. Austin, D.S. Lee, and J.V. Tu Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists Circulation 108 2003 184 191 (Pubitemid 36871301)
16. J.L. Ambrus, C.M. Ambrus, I.B. Mink, and J.W. Pickren Causes of death in cancer patients J Med 6 1975 61 64
17. S.I. Cuervo, J.A. Cortes, R. Sanchez, J.Y. Rodriguez, E. Silva, D. Tibavizco, and P. Arroyo Risk factors for mortality caused by staphylococcus aureus bacteremia in cancer patients Enferm Infecc Microbiol Clin 28 2010 349 354
18. T. Kuittinen, E. Jantunen, E. Vanninen, H. Mussalo, O. Vuolteenaho, and M. Ala-Kopsala Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation Eur J Haematol 77 2006 120 127
19. O. Pagani, C. Sessa, F. Nole, D. Crivellari, D. Lombardi, and B. Thurlimann Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: a multicentric phase I-II study Ann Oncol 11 2000 985 991